SKU: TSM10≥ 99% HPLC
GHRH-T
Research Compound · Research use only

GHRH-TGHRH-T is a synthetic 44-amino acid peptide consisting of GHRH(1-44) with N-terminal trans-3-hexenoic acid modification, available as a lyophilized powder for laboratory research.

$53.99/ vial · 10mg
In stock
Est. Arrival: 11/25/2026Ships today if ordered by 4PM EST
Select Size
Volume Discounts
1
Purity
99%+
Form
Lyophilized Powder
Quantity
10 mg
Storage
Store lyophilized at -20 °C, sealed, away from light and moisture
Batch / Lot
202612-01-TSM
99%+ PurityHPLC · third-party
COA Includedlot 202609-01-TSM
USA BasedMidwest Region
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
$53.99GHRH-T · 10mg × 1

Product Details

GHRH-T is the full 44-amino acid human GHRH sequence with added trans-3-hexenoic acid at N-terminus for stability.


N-terminal modification protects from aminopeptidase degradation. Full-length 44-amino acid sequence distinguishes it from sermorelin (GHRH 1-29). Soluble in sterile water or bacteriostatic water. Store at -20°C.


Disclaimer: For laboratory and research purposes only. Not intended for human consumption.

Frequently Asked Questions About GHRH-T

Answers summarize published research and are provided for laboratory research purposes only.

GHRH-T is a synthetic 44 amino acid peptide made up of the full human GHRH(1-44) sequence with a trans-3-hexenoic acid group attached at the N-terminus. It belongs to the class of growth hormone releasing hormone analogs. Research studies have examined GHRH-T for its activity at the GHRH receptor, its stability against enzymatic degradation, and its effects on growth hormone signaling and body composition in animal models and human clinical trials.
Research studies have shown that GHRH-T binds and activates the GHRH receptor on pituitary somatotroph cells, a class B G-protein coupled receptor that signals through cAMP. Researchers have reported that this activation stimulates the pulsatile release of growth hormone in the models studied, which in turn raises IGF-1 signaling. Because GHRH-T works upstream through the natural GHRH pathway, published research describes its effect as preserving the normal feedback control of the axis.
GHRH-T is one of the better studied GHRH analogs. Evidence includes in vitro receptor assays, animal models, and multiple phase 3 clinical trials. A pharmaceutical form of GHRH-T has been approved as a prescription drug for a specific indication in some jurisdictions. The GHRH-T sold by Biotech Compounds is a research grade lyophilized peptide, not that pharmaceutical product, and is supplied for laboratory investigation only.
Native GHRH is broken down quickly in circulation by aminopeptidases and by the enzyme DPP-4, which cleaves near the N-terminus. The trans-3-hexenoic acid group on GHRH-T caps that end of the peptide. Research studies have shown that this modification protects GHRH-T from aminopeptidase degradation and extends its activity compared with the unmodified GHRH sequence. It is the main structural reason GHRH-T behaves differently from native GHRH in stability assays.
GHRH-T and Sermorelin are both GHRH analogs but differ in length and stability. GHRH-T is the full 44 amino acid GHRH sequence with an N-terminal hexenoic acid cap. Sermorelin is GHRH(1-29), a truncated 29 amino acid fragment without that modification. Research studies have reported that Sermorelin is degraded quickly by peptidases, while GHRH-T resists that breakdown. Both activate the GHRH receptor in research models, so GHRH-T is often the longer acting comparator in studies.
Yes. GHRH-T from Biotech Compounds is listed at 99 percent or higher purity and each lot is tested by an independent laboratory. The Certificate of Analysis for GHRH-T is available on the product page and reports identity and purity results for the batch. Researchers should confirm the lot number on the GHRH-T vial matches the posted COA before beginning an experiment.
GHRH-T has a molecular weight of approximately 5135.9 g/mol and the molecular formula C221H366N72O67S. It is a 44 amino acid peptide, which makes GHRH-T one of the larger peptides in the Biotech Compounds catalog. The single sulfur atom in the formula comes from the methionine residue in the GHRH sequence, and the hexenoic acid cap adds to the total mass relative to native GHRH.

Purity, documented